Login / Signup

Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol.

Yvette N LöwensteynNatalie I MazurHarish NairJoukje E WillemsenGhislaine van ThielLouis J Bontnull null
Published in: BMC infectious diseases (2021)
NL9519, May 27, 2021.
Keyphrases
  • respiratory syncytial virus
  • intensive care unit
  • study protocol
  • respiratory tract
  • randomized controlled trial
  • clinical trial
  • mechanical ventilation
  • open label
  • silver nanoparticles
  • double blind
  • young adults